Reuters logo
BRIEF-Pfizer to have exclusive rights to distribute, commercialize CRESEMBA in Europe
June 14, 2017 / 5:30 PM / 6 months ago

BRIEF-Pfizer to have exclusive rights to distribute, commercialize CRESEMBA in Europe

June 14 (Reuters) - Pfizer Inc:

* Pfizer receives exclusive commercialization rights in Europe for CRESEMBA, a novel treatment for potentially life-threatening fungal infections among immunocompromised patients

* Pfizer will have exclusive rights to distribute and commercialize CRESEMBA in Europe, including Austria, France, Germany, Italy and UK

* Pfizer will be responsible for additional CRESEMBA launches, predominantly in Europe, which are expected throughout 2017 and 2018​

* Basilea will remain marketing authorization holder for CRESEMBA in European Union Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below